Company: EDSA
Filing Date: 2025-08-08
Form Type: 8-K
Source: 0001171843-25-005235
Chunk: 0

Company: Edesa Biotech, Inc.
Filing Date: 2025-08-08
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02. Results of Operations and Financial Condition.

On August 8, 2025, Edesa Biotech, Inc. (the “ Company”) issued a press release announcing its financial results for the three and nine months ended June 30, 2025 (the “ Earnings Release”). The full text of the Earnings Release is attached hereto as Exhibit 99.1. The information furnished herein and therein shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”) or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                  
         99.1      Press release issued by Edesa Biotech, Inc. dated August 8, 2025.            
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)